Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > How should the stock react Monday?

<< Previous

Bullboard Posts

Next >>

Comment by Wino115on Apr 11, 2021 7:39am

126 Views

Post# 32973860

RE:RE:RE:RE:How should the stock react Monday?

I assume you mean revenues since there are no earnings. Keeping up the revenue momentum would be nice. Revenue mu,triple is fair, not wildly cheap like it was. Getting proper valuation for the pipeline is the big value enhancer.

PinnacleX wrote:

Wino115 wrote: The last after hour market trade was at $3.70. Maybe we can break through and hold $4,00 convincingly. We need that to get FTV's springtime $5 target.

Who cares about someones target, just beat on earnings, rest will take care of itself.